Human intestinal absorption of imidacloprid with Caco-2 cells as enterocyte model

Toxicology and Applied Pharmacology

Volumn 194, Issue 1, 2004, Pages 1-9

  Brunet, Jean Luc ^a   Maresca, Marc ^b   Fantini, Jacques ^b   Belzunces, Luc P ^a  

^a Laboratoire de Toxicologie Environnementale   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

Author keywords

ABC transporters; Caco 2; Efflux; Human intestinal absorption; Imidacloprid; Neonicotinoid; Pharmacokinetic; Transepithelial transport; Uptake

Indexed keywords

ABC TRANSPORTER; ADENOSINE TRIPHOSPHATE; BUFFER; CELL SURFACE PROTEIN; DAUNORUBICIN; GLYCOPROTEIN P; IMIDACLOPRID; PACLITAXEL; SODIUM AZIDE; SODIUM ION; TRYPSIN; VINCRISTINE;

ARTICLE; CELL STRAIN CACO 2; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ENERGY; EPITHELIUM; EXPOSURE; HUMAN; HUMAN CELL; INTESTINE ABSORPTION; INTESTINE CELL; INTRACELLULAR SPACE; INTRACELLULAR TRANSPORT; MAMMAL; MEMBRANE PERMEABILITY; MOLECULAR WEIGHT; NONHUMAN; PH; POLARIZATION; RISK ASSESSMENT; TEMPERATURE DEPENDENCE;

ARRHENIUS; MAMMALIA;

EID: 0346689060     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.taap.2003.08.018     Document Type: Article

References (41)

1. Artursson P., Palm K., Luthman K. Caco-2 monolayers in experimental and theoretical predictions of drug transport. Adv. Drug Delivery Rev. 46:2001;27-43.
2. Chao L.S., Casida J.E. Interaction of imidacloprid metabolites and analogs with the nicotinic acetylcholine receptor of mouse brain in relation to toxicity. Pestic. Biochem. Physiol. 58:1997;77-88.
3. Delezay O., Yahi N., Tamalet C., Baghdiguian S., Boudier J.A., Fantini J. Direct effect of type 1 human immunodeficiency virus (HIV-1) on intestinal epithelial cell differentiation: relationship to HIV-1 enteropathy. Virology. 238:1997;231-242.
4. Delie F., Rubas W. A human colonic cell line sharing similarities with enterocytes as a model to examine oral absorption: advantages and limitations of the Caco-2 model. Crit. Rev. Ther. Drug Carrier Syst. 14:1997;221-286.
5. Fantini J., Cook D.G., Nathanson N., Spitalnik S.L., Gonzalez-Scarano F. Infection of colonic epithelial cell lines by type 1 human immunodeficiency virus is associated with cell surface expression of galactosylceramide, a potential alternative gp120 receptor. Proc. Natl. Acad. Sci. U.S.A. 90:1993;2700-2704.
6. Fernandez-Alba A.R., Tejedor A., Aguera A., Contreras M., Garrido J. Determination of imidacloprid and benzimidazole residues in fruits and vegetables by liquid chromatography-mass spectrometry after ethyl acetate multiresidue extraction. J. AOAC Int. 83:2000;748-755.
7. Flores-Cespedes F., Gonzales-Pradas E., Fernandez-Perez M., Vilafranca-Sanchez M., Socias-Viciana M., Urena-Amate M.D. Effects of dissolved organic carbon on sorption and mobility of imidacloprid in soil. J. Environ. Qual. 31:2002;880-888.
8. Gonzalez-Pradas E., Flores-Cespedes F., Urena-Amate M.D., Fernandez-Perez M., Garratt J., Wilkins R. Leaching and persistence of imidacloprid and diuron in a citrus crop in Valencia. Fresenius Environ. Bull. 9:2000;638-645.
9. Hellpointer E. Lysimeter study of imidacloprid after seed treatment of sugar beet in two crop rotations. A.C.S. Symp. Ser. 699:1998;40-51.
10. Hirohashi T., Suzuki H., Chu X.Y., Tamai I., Tsuji A., Sugiyama Y. Function and expression of multidrug resistance-associated protein family in human colon adenocarcinoma cells (Caco-2). J. Pharmacol. Exp. Ther. 292:2000;265-270.
11. Holland I.B., Blight M.A. ABC-ATPases, adaptable energy generators fuelling transmembrane movement of a variety of molecules in organisms from bacteria to humans. J. Mol. Biol. 293:1999;381-399.
12. Kalpana P., Gajbhiye V.T., Agnihotri N.P. Persistence and leaching of imidacloprid in soil. Ann. Plant Port. Sci. 10:2002;176-178.
13. Klein I., Sarkadi B., Varadi A. An inventory of the human ABC proteins. Biochim. Biophys. Acta. 1461:1999;237-262.
14. Lansdell S.J., Millar N.S. The influence of nicotinic receptor subunit composition upon agonist, alpha-bungarotoxin and insecticide (imidacloprid) binding affinity. Neuropharmacology. 39:2000;671-679.
15. Le Ferrec E., Chesne C., Artusson P., Brayden D., Fabre G., Gires P., Guillou F., Rousset M., Rubas W., Scarino M.L. In vitro models of the intestinal barrier. The report and recommendations of ECVAM Workshop 46. European Centre for the Validation of Alternative methods. Altern. Lab. Anim. 29:2001;649-668.
16. Leier I., Jedlitschky G., Buchholz U., Cole S.P., Deeley R.G., Keppler D. The MRP gene encodes an ATP-dependent export pump for leukotriene C4 and structurally related conjugates. J. Biol. Chem. 269:1994;27807-27810.
17. 3H]- imidacloprid in the insect acetylcholine receptor. Pestic. Biochem. Physiol. 46:1993;40-46.
18. Lu P., Liu R., Sharom F.J. Drug transport by reconstituted P-glycoprotein in proteoliposomes. Effect of substrates and modulators, and dependence on bilayer phase state. Eur. J. Biochem. 268:2001;1687-1697.
19. Mahfoud R., Maresca M., Garmy N., Fantini J. The mycotoxin patulin alters the barrier function of the intestinal epithelium: mechanism of action of the toxin and protective effects of glutathione. Toxicol. Appl. Pharmacol. 181:2002;209-218.
20. Maresca M., Mahfoud R., Pfohl-Leszkowicz A., Fantini J. The mycotoxin ochratoxin A alters intestinal barrier and absorption functions but has no effect on chloride secretion. Toxicol. Appl. Pharmacol. 176:2001;54-63.
21. Markwell M.A., Haas S.M., Bieber L.L., Tolbert N.E. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal. Biochem. 87:1978;206-210.
22. Meaney C., O'Driscoll C. Mucus as a barrier to the permeability of hydrophilic and lipophilic compounds in the absence and presence of sodium taurocholate micellar systems using cell culture models. Eur. J. Pharm. Sci. 8:1999;167-175.
23. Nakayama H., Numakawa T., Ikeuchi T., Hatanaka H. Nicotine-induced phosphorylation of extracellular signal-regulated protein kinase and CREB in PC12h cells. J. Neurochem. 79:2001;489-498.
24. Oi M. Time-dependent sorption of imidacloprid in two different soils. J. Agric. Food Chem. 47:1999;327-332.
25. Okazawa A., Nakagawa Y., Akamatsu M., Ueno T., Nishimura K. Comparison of the binding activities of chloronicotinyl insecticides toward the nicotinic acetylcholine receptors from rats and houseflies. J. Pestic. Sci. 25:2000;40-43.
26. Oliveira R.S. Jr., Koskinen W.C., Werdin N.R., Yen P.Y. Sorption of imidacloprid and its metabolites on tropical soils. J. Environ. Sci. Health, Part B. 35:2000;39-49.
27. Pinto M., Robine-Leon S., Appay M.D., Kedlinger M., Triadou N., Dussaulx E., Lacroix B., Simon-Assmann P., Haffen K., Fogh J., Zweibaum J. Enterocyte-like differentiation and polarization in the human colon carcinoma cell line Caco-2 in culture. Biol. Cell. 47:1981;323-330.
28. Rousset M. The human colon carcinoma cell lines HT-29 and Caco-2: two in vitro models for the study of intestinal differentiation. Biochimie. 68:1986;1035-1040.
29. Sarkar M.A., Roy S., Kole R.K., Chowdhury A. Persistence and metabolism of imidacloprid in different soils of West Bengal. Pest Manag. Sci. 57:2001;598-602.
30. Schulz-Jander D.A., Casida J.E. Imidacloprid insecticide metabolism: human cytochrome P450 isozymes differ in selectivity for imidazolidine oxidation versus nitroimine reduction. Toxicol. Lett. 132:2002;65-70.
31. Schulz-Jander D.A., Leimkuehler W.M., Casida J.E. Neonicotinoid insecticides: reduction and cleavage of imidacloprid nitroimine substituent by liver microsomal and cytosolic enzymes. Chem. Res. Toxicol. 15:2002;1158-1165.
32. Suchail S., Guez D., Belzunces L.P. Discrepancy between acute and chronic toxicity induced by imidacloprid and its metabolites in Apis mellifera. Environ. Toxicol. Chem. 20:2001;2482-2486.
33. Suzuki H., Sugiyama Y. Role of metabolic enzymes and efflux transporters in the absorption of drugs from the small intestine. Eur. J. Pharm. Sci. 12:2000;3-12.
34. Tomizawa M., Casida J.E. Minor structural changes in nicotinoid insecticides confer differential subtype selectivity for mammalian nicotinic acetylcholine receptors. Br. J. Pharmacol. 127:1999;115-122.
35. Tomizawa M., Casida J.E. Imidacloprid, thiacloprid, and their imine derivatives up-regulate the alpha 4 beta 2 nicotinic acetylcholine receptor in M10 cells. Toxicol. Appl. Pharmacol. 169:2000;114-120.
36. Tomizawa M., Casida J.E. Desnitro-imidacloprid activates the extracellular signal-regulated kinase cascade via the nicotinic receptor and intracellular calcium mobilization in N1E-115 cells. Toxicol. Appl. Pharmacol. 184:2002;180-186.
37. Tomizawa M., Yamamoto I. Structure-activity relationships of nicotinoïds and imidacloprid analogs. J. Pestic. Sci. 18:1993;91-98.
38. Tomizawa M., Lee D.L., Casida J.E. Neonicotinoid insecticides: molecular features conferring selectivity for insect versus mammalian nicotinic receptors. J. Agric. Food Chem. 48:2000;6016-6024.
39. Westwood F., Bean K.M., Dewar A.M., Bromilow R.H., Chamberlain K. Movement and persistence of [C-14]imidacloprid in sugar-beet plants following application to pelleted sugar-beet seed. Pestic. Sci. 52:1998;97-103.
40. Yamashita S., Furubayashi T., Kataoka M., Sakane T., Sezaki H., Tokuda H. Optimized conditions for prediction of intestinal drug permeability using Caco-2 cells. Eur. J. Pharm. Sci. 10:2000;195-204.
41. Yee S. In vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestinal) absorption in man-fact or myth. Pharm. Res. 14:1997;763-766.